NRG-GU006 at the 2025 ASTRO Clinical Trials Session

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/60/e8/af/60e8af10-bdff-df62-65d2-b67a544373d1/mza_13084884134369712645.jpg/600x600bb.jpg

The NRG Oncology Podcast

NRG Oncology

34 episodes

2 days ago

The NRG Oncology Podcast, developed by NRG Oncology, is hosted by Drs. Stephen Chun and Lauren Henke. Stephen and Lauren delve into a variety of topics impacting the oncology community via interviews with various stakeholders throughout the NRG Oncology organization.

Medicine

Health & Fitness

RSS

All content for The NRG Oncology Podcast is the property of NRG Oncology and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Medicine

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/41380161/41380161-1758895185289-db8e3c3d705fa.jpg

NRG-GU006 at the 2025 ASTRO Clinical Trials Session

The NRG Oncology Podcast

36 minutes 14 seconds

1 month ago

NRG-GU006 at the 2025 ASTRO Clinical Trials Session

Our co-hosts discuss NRG-GU006 with Dr. Daniel Spratt. The results of NRG-GU006, a phase II clinical study in recurrent prostate cancer, were presented as a part of the 2025 American Society for Radiation Oncology (ASTRO) Annual Meeting Clinical Trials Session.